|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
cannabidiolic acid results in increased expression of ACOX1 mRNA |
CTD |
PMID:30611848 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
increases expression |
ISO |
cannabidiolic acid results in increased expression of BHLHE41 mRNA |
CTD |
PMID:25242400 |
|
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions increases expression |
ISO |
cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] cannabidiolic acid results in increased expression of CEBPA mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
ISO |
cannabidiolic acid results in increased expression of CPT1A mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA] cannabidiolic acid results in increased expression of FABP4 mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
ISO |
cannabidiolic acid results in decreased expression of FOS mRNA |
CTD |
PMID:27530354 PMID:30496661 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Htr1a |
5-hydroxytryptamine receptor 1A |
increases expression |
ISO |
cannabidiolic acid results in increased expression of HTR1A mRNA |
CTD |
PMID:27530354 |
|
NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:36,694,174...36,695,442
|
|
G |
Id1 |
inhibitor of DNA binding 1 |
decreases expression |
ISO |
cannabidiolic acid results in decreased expression of ID1 mRNA |
CTD |
PMID:25242400 |
|
NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:141,211,267...141,212,419
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
cannabidiolic acid results in decreased expression of IGF1 protein |
CTD |
PMID:33010341 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA]; cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]; cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] |
CTD |
PMID:30611848 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions increases expression |
ISO |
cannabidiolic acid binds to and results in increased activity of PPARA protein cannabidiolic acid results in increased expression of PPARA mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions decreases expression |
ISO |
cannabidiolic acid results in increased expression of PPARG mRNA cannabidiolic acid binds to and results in increased activity of PPARG protein; cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] cannabidiolic acid results in decreased expression of PPARG protein |
CTD |
PMID:28853159 PMID:30611848 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression multiple interactions |
ISO |
cannabidiolic acid results in decreased expression of PTGS2 mRNA cannabidiolic acid inhibits the reaction [GW 501516 results in increased expression of PTGS2 mRNA]; cannabidiolic acid promotes the reaction [GSK0660 results in decreased expression of PTGS2 mRNA] |
CTD |
PMID:25242400 PMID:27530354 PMID:30496661 PMID:32238697 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
increases activity |
ISO |
cannabidiolic acid results in increased activity of TRPA1 protein |
CTD |
PMID:31096838 |
|
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
|
|
G |
Trpm8 |
transient receptor potential cation channel, subfamily M, member 8 |
decreases expression |
ISO |
cannabidiolic acid results in decreased expression of TRPM8 mRNA |
CTD |
PMID:27530354 |
|
NCBI chr 9:88,897,039...88,990,167
Ensembl chr 9:88,903,880...88,988,552
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases activity multiple interactions |
ISO |
cannabidiolic acid results in increased activity of TRPV1 protein [cannabidiolic acid results in increased activity of TRPV1 protein] which results in increased uptake of Calcium |
CTD |
PMID:31096838 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv2 |
transient receptor potential cation channel, subfamily V, member 2 |
multiple interactions increases expression |
ISO |
[cannabidiolic acid results in increased activity of TRPV2 protein] which results in increased uptake of Calcium cannabidiolic acid results in increased expression of TRPV2 mRNA |
CTD |
PMID:27530354 PMID:31096838 |
|
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
|
|
|
G |
Acox1 |
acyl-CoA oxidase 1 |
increases expression |
ISO |
cannabigerolic acid results in increased expression of ACOX1 mRNA |
CTD |
PMID:30611848 |
|
NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
increases expression |
ISO |
cannabigerolic acid results in increased expression of CPT1A mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions increases expression |
ISO |
cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA] cannabigerolic acid results in increased expression of FABP4 mRNA |
CTD |
PMID:30611848 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FABP4 mRNA]; cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] |
CTD |
PMID:30611848 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
increases expression multiple interactions |
ISO |
cannabigerolic acid results in increased expression of PPARA mRNA cannabigerolic acid binds to and results in increased activity of PPARA protein |
CTD |
PMID:30611848 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression decreases expression multiple interactions |
ISO |
cannabigerolic acid results in increased expression of PPARG mRNA cannabigerolic acid results in decreased expression of PPARG protein cannabigerolic acid binds to and results in increased activity of PPARG protein; cannabigerolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA] |
CTD |
PMID:28853159 PMID:30611848 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
multiple interactions increases activity |
ISO |
[cannabigerolic acid results in increased activity of TRPV1 protein] which results in increased uptake of Calcium |
CTD |
PMID:31096838 |
|
NCBI chr10:57,851,428...57,876,513
Ensembl chr10:57,851,428...57,876,513
|
|
G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
affects activity |
EXP |
cannabigerolic acid affects the activity of TRPV3 protein |
CTD |
PMID:21726418 |
|
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
|
|